These limitations on the BTNX NTS are highly appropriate, as we identified e.g. etodesnitazene to own the same in vitro potency and efficacy as fentanyl [seven, thirteen] and as it might probably give PWUD a Fake perception of basic safety. In addition, the detectability of nitazene analogues in drug samples can be impacted by solubility challenges